The Board of Directors of Krebs Biochemicals and Industries Limited, at its meeting held today have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021.
For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 12.1121 crore, against ₹16.7655 crore in the corresponding quarter of the previous year (YoY) and ₹6.7852 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹-10.8485 crore, against ₹-6.3903 crore in the corresponding quarter of the previous year (YoY) and ₹-9.4235 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹-5.05, against ₹-3.26 in the corresponding quarter of the previous year (YoY) and ₹-4.37 in previous quarter (QoQ).
Total Income | ₹ 12.1121 crs | ₹6.7852 crs | 78.51% | ₹16.7655 crs | -27.76% |
Net Profit | ₹-10.8485 crs | ₹-9.4235 crs | 15.12% | ₹-6.3903 crs | 69.77 % |
EPS | ₹-5.05 | ₹-4.37 | 15.56% | ₹-3.26 | 54.91% |
For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹18.8973 crore, against ₹28.3847 crore in the previous year (YoY) (Half Year Ended FY 2021).
The net profit / (loss) was at ₹-20.2720 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹-13.1118 crore in the previous year (YoY) (Half Year Ended FY 2021).
The Earnings Per Share stood at ₹-9.42 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹-6.68 in the previous year (YoY) (Half Year Ended FY 2021).
Total Income | ₹18.8973 crs | ₹28.3847 crs | -33.42% |
Net Profit | ₹-20.2720 crs | ₹-13.1118 crs | 54.61% |
EPS | ₹-9.42 | ₹-6.68 | 41.02% |
Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 173.10 as compared to the previous close of Rs. 174.15. The total number of shares traded during the day was 1390 in over 76 trades.
The stock hit an intraday high of Rs. 176.00 and intraday low of 171.00. The net turnover during the day was Rs. 240754.00.
Source : Equity Bulls
Keywords
KrebsBiochemicalsandIndustries
Q2FY22
H1FY22
ResultUpdate